THE DEEP-SEA BIOLOGY SOCIETY
The society enables the exchange of information on deep-sea biology through its membership program, digital communication platforms and the organisation and sponsorship of scientific meetings. We issue grants such as travel and career development awards. We give annual and triennial prizes recognising excellence in research. We conduct a mentoring program connecting senior and junior researchers.
Financial health, per its FY2024 accounts
The accounts state that the charity holds unrestricted reserves of £71,722, which the trustees consider sufficient to cover a typical year of expenditure. The charity reports no investments, no defined-benefit pension deficits, and no material uncertainties regarding its ability to continue as a going concern.
What the accounts disclose
“The charity's principal source of funds are membership fees, which have provided a steady income stream from the time of the society’s formation.” — page 8
“The charity seeks to hold reserves in line with charity commission guidance. We aim to hold funds sufficient to cover a typical year of expenditure.” — page 8
Trustees
- Dr Michelle Taylorchair
- Alycia Jane Smith
- Ariane Buckenmeyer
- Dr Alexis Weinnig
- Dr Franck Lejzerowicz
- Dr Heather Judkins
- Dr Julia Sigwart
- Dr Maeva Perez
- Dr Mari Heggernes Eilertsen
- Dr Pierre Methou
- Janet Ferguson-Roberts
- Julia Johnstone
- Katharine Bigham
- Lucy Goodwin
- Sofia Graca Aranha Carvalho Ramos
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £26k | £32k |
| 31/12/2023 | £24k | £39k |
| 31/12/2022 | £8k | £9k |
| 31/12/2021 | £34k | £39k |
| 31/12/2020 | £34k | £8k |
Common questions
Is THE DEEP-SEA BIOLOGY SOCIETY financially healthy?
Per its FY2024 accounts: The accounts state that the charity holds unrestricted reserves of £71,722, which the trustees consider sufficient to cover a typical year of expenditure. The charity reports no investments, no defined-benefit pension deficits, and no material uncertainties regarding its ability to continue as a going concern. Its FY2024 accounts were independently examined.